With a growing list of regulatory approvals sparking sustained interest in producing monoclonal antibodies, Eppendorf has been supporting researchers who are working with both bacterial and ...

Monoclonal antibodies are novel therapeutic agents ... difficulties since duration and severity of disease, concomitant medications and illnesses, dates of studies performed, inclusion/exclusion ...

Monoclonal antibodies offer a major advantage in drug discovery, and it’s no longer difficult to quickly make a lot of new antibodies. But this leads to their biggest drawback. Screening and ...

Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for ...

With over 80 publications, Mohta has expertise in the use of biological drugs for both cutaneous and systemic disorders. View Full Profile. Learn about our Editorial Policies. Scientists create ...

FMC63, an IgG2a mouse monoclonal antibody, targets CD19. To date, a majority of the reported CART19 trials include the anti-CD19 scFv extracted from FMC63, such as both the FDA-approved CARs ...

The monoclonal antibody drug is used for the control of pain associated with osteoarthritis in dogs. Librela was approved by the FDA on May 5, 2023, and introduced to the market later that year.